1. Home
  2. WAT vs FMS Comparison

WAT vs FMS Comparison

Compare WAT & FMS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WAT
  • FMS
  • Stock Information
  • Founded
  • WAT 1958
  • FMS 1996
  • Country
  • WAT United States
  • FMS Germany
  • Employees
  • WAT N/A
  • FMS N/A
  • Industry
  • WAT Biotechnology: Laboratory Analytical Instruments
  • FMS Misc Health and Biotechnology Services
  • Sector
  • WAT Industrials
  • FMS Health Care
  • Exchange
  • WAT Nasdaq
  • FMS Nasdaq
  • Market Cap
  • WAT 17.8B
  • FMS 15.0B
  • IPO Year
  • WAT 1995
  • FMS 1996
  • Fundamental
  • Price
  • WAT $309.50
  • FMS $25.10
  • Analyst Decision
  • WAT Hold
  • FMS Sell
  • Analyst Count
  • WAT 14
  • FMS 2
  • Target Price
  • WAT $374.07
  • FMS $30.00
  • AVG Volume (30 Days)
  • WAT 563.4K
  • FMS 276.0K
  • Earning Date
  • WAT 10-31-2025
  • FMS 11-04-2025
  • Dividend Yield
  • WAT N/A
  • FMS 2.30%
  • EPS Growth
  • WAT 10.77
  • FMS 23.39
  • EPS
  • WAT 11.09
  • FMS 2.62
  • Revenue
  • WAT $3,046,056,000.00
  • FMS $22,922,038,756.00
  • Revenue This Year
  • WAT $7.19
  • FMS $2.10
  • Revenue Next Year
  • WAT $6.40
  • FMS $3.13
  • P/E Ratio
  • WAT $27.91
  • FMS $18.64
  • Revenue Growth
  • WAT 5.89
  • FMS 0.53
  • 52 Week Low
  • WAT $275.05
  • FMS $18.94
  • 52 Week High
  • WAT $423.56
  • FMS $30.46
  • Technical
  • Relative Strength Index (RSI)
  • WAT 58.10
  • FMS 49.19
  • Support Level
  • WAT $286.14
  • FMS $24.22
  • Resistance Level
  • WAT $302.94
  • FMS $25.72
  • Average True Range (ATR)
  • WAT 8.17
  • FMS 0.27
  • MACD
  • WAT 2.35
  • FMS 0.04
  • Stochastic Oscillator
  • WAT 97.05
  • FMS 58.67

About WAT Waters Corporation

Water sells liquid chromatography, mass spectrometry, and thermal analysis tools. These analytical instruments provide essential information on various products, such as their molecular structures and physical properties, to help clients enhance the health and well-being of end users. As a percentage of sales in 2024, Waters generated 58% from biopharmaceutical customers, 31% from industrial clients, and 11% from academic/government institutions. In early 2026, Waters plans to merge with BD's life science and diagnostics business, which will substantially change those concentrations. Waters will wind up with more concentration in diagnostics (versus none now) and discovery-related life science tools.

About FMS Fresenius Medical Care AG

Fresenius Medical Care is the largest dialysis company in the world, treating about 300,000 patients from nearly 3,700 clinics worldwide as of December 2024. In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market, creating the world's only fully integrated dialysis business. Services account for about three-fourths of sales, while the balance is generated from medical technology products that enable dialysis treatments.

Share on Social Networks: